Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30802271 | 1.00 | APOBEC3G (0.36) | APOBEC3GMEN1MAPTKMT2ANPSR1 | |
| SCHEMBL29661845 | 0.83 | LMNA (0.39) | HTR7MAOAMAOBALDH1A1LMNA | |
| SCHEMBL8420683 | 0.83 | LMNA (0.39) | HTR7MAOAMAOBALDH1A1LMNA | |
| SCHEMBL951192 | 0.79 | HTR7 (0.31) | HTR7MAOAMAOB | |
| SCHEMBL28029391 | 0.79 | HTR7 (0.35) | MEN1MAPTKMT2AHTR7MAOA | |
| SCHEMBL31412108 | 0.77 | APOBEC3G (0.46) | APOBEC3GMEN1MAPTKMT2ANPSR1 | |
| SCHEMBL224791 | 0.77 | APOBEC3G (0.46) | APOBEC3GMEN1MAPTKMT2ANPSR1 | |
| SCHEMBL355898 | 0.75 | — | — | |
| SCHEMBL1814655 | 0.74 | TDP1 (0.31) | — | |
| SCHEMBL943477 | 0.74 | APOBEC3G (0.33) | APOBEC3GMEN1MAPTKMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987516-B2 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| US-8907020-B2 | Golf ball | SRI SPORTS LIMITED (JP) | 2014-12-09 | — | — | US | disclosed |
| US-8877869-B2 | Method for selecting organic sulfur compound for golf ball, method for producing golf ball, and golf ball | SRI SPORTS LIMITED (JP) | 2014-11-04 | — | — | US | disclosed |
| EP-2468722-B1 | Process for producing arylsulfur halotetrafluorides | UBE INDUSTRIES (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2468721-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-2468720-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-11-27 | — | — | EP | disclosed |
| US-8592526-B2 | Golf ball | SRI SPORTS LIMITED (JP) | 2013-11-26 | — | — | US | disclosed |
| EP-2468719-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-10-16 | — | — | EP | disclosed |
| US-8399720-B2 | Methods for producing fluorinated phenylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| EP-2468721-A1 | Process for producing arylsulfur pentafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-1863785-A1 | NOVEL THIOPHENE SULFOXIMINES FOR TREATING CMPLEMENT-MEDIATED DESEASES AND CONDITIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-12-12 | — | — | EP | disclosed |
| US-20070066667-A1 | Novel thiophene sulfoximines, compositions thereof, and methods treating complement-mediated diseases and conditions | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-22 | — | — | US | disclosed |
| US-7125346-B2 | Solid golf ball | SRI SPORTS LIMITED (JP) | 2006-10-24 | — | — | US | disclosed |
| WO-2006101860-A1 | NOVEL THIOPHENE SULFOXIMINES FOR TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-09-28 | — | — | WO | disclosed |
| US-20050202902-A1 | Solid golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. | 2005-09-15 | — | — | US | disclosed |
| US-6838524-B2 | Solid golf ball | SUMITOMO RUBBER INDUSTRIES LIMITED (JP) | 2005-01-04 | — | — | US | disclosed |
| US-6646165-B2 | Reacting halothiophenol compound with an alkali metal hydroxide to obtain an alkali metal halothiophenolate compound; oxidizing in the presence of a mineral acid to produce bishalophenyl disulfide | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2003-11-11 | — | — | US | disclosed |
| US-20030060665-A1 | Process for producing bishalophenyl disulfide | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2003-03-27 | — | — | US | disclosed |
| US-20030032501-A1 | Solid golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2003-02-13 | — | — | US | disclosed |
| EP-1277731-A1 | PROCESS FOR PRODUCING BISHALOPHENYL DISULFIDE | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2003-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066667-A1 | Novel thiophene sulfoximines, compositions thereof, and methods treating complement-mediated diseases and conditions | C5, C1QBP, C1R | APOBEC3G 4591/4885MEN1 2090/4885MAPT 4246/4885 |
| US-20030060665-A1 | Process for producing bishalophenyl disulfide | MPST, TST, GRHPR | APOBEC3G 4272/4885MEN1 2913/4885MAPT 2177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.